vs

Side-by-side financial comparison of DHI GROUP, INC. (DHX) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $31.4M, roughly 1.4× DHI GROUP, INC.). DHI GROUP, INC. runs the higher net margin — 3.0% vs -90.4%, a 93.5% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -9.8%). DHI GROUP, INC. produced more free cash flow last quarter ($5.7M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -6.7%).

DHI is an international water software development and engineering consultancy firm with headquarters in Denmark. The profit-for-purpose organisation addresses all challenges in water environments through consultancy services, MIKE Powered by DHI water modelling software, business applications, data portals and operational services. DHI has 30 offices throughout the world, with software development centres in Singapore and Denmark, and approximately 1050 employees.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

DHX vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.4× larger
PACB
$44.6M
$31.4M
DHX
Growing faster (revenue YoY)
PACB
PACB
+23.6% gap
PACB
13.8%
-9.8%
DHX
Higher net margin
DHX
DHX
93.5% more per $
DHX
3.0%
-90.4%
PACB
More free cash flow
DHX
DHX
$25.6M more FCF
DHX
$5.7M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-6.7%
DHX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DHX
DHX
PACB
PACB
Revenue
$31.4M
$44.6M
Net Profit
$951.0K
$-40.4M
Gross Margin
37.1%
Operating Margin
10.4%
-92.3%
Net Margin
3.0%
-90.4%
Revenue YoY
-9.8%
13.8%
Net Profit YoY
-6.9%
-1802.7%
EPS (diluted)
$0.03
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHX
DHX
PACB
PACB
Q4 25
$31.4M
$44.6M
Q3 25
$32.1M
$38.4M
Q2 25
$32.0M
$39.8M
Q1 25
$32.3M
$37.2M
Q4 24
$34.8M
$39.2M
Q3 24
$35.3M
$40.0M
Q2 24
$35.8M
$36.0M
Q1 24
$36.0M
$38.8M
Net Profit
DHX
DHX
PACB
PACB
Q4 25
$951.0K
$-40.4M
Q3 25
$-4.3M
$-38.0M
Q2 25
$-841.0K
$-41.9M
Q1 25
$-9.4M
$-426.1M
Q4 24
$1.0M
$2.4M
Q3 24
$-200.0K
$-60.7M
Q2 24
$943.0K
$-173.3M
Q1 24
$-1.5M
$-78.2M
Gross Margin
DHX
DHX
PACB
PACB
Q4 25
37.1%
Q3 25
85.7%
41.4%
Q2 25
84.0%
36.9%
Q1 25
83.4%
-3.7%
Q4 24
25.6%
Q3 24
85.6%
25.0%
Q2 24
85.5%
16.5%
Q1 24
86.5%
29.1%
Operating Margin
DHX
DHX
PACB
PACB
Q4 25
10.4%
-92.3%
Q3 25
-14.0%
-101.1%
Q2 25
-3.9%
-112.8%
Q1 25
-27.5%
-1154.5%
Q4 24
5.0%
-390.1%
Q3 24
1.8%
-160.3%
Q2 24
5.6%
-488.3%
Q1 24
5.5%
-209.6%
Net Margin
DHX
DHX
PACB
PACB
Q4 25
3.0%
-90.4%
Q3 25
-13.3%
-98.9%
Q2 25
-2.6%
-105.4%
Q1 25
-28.9%
-1146.8%
Q4 24
2.9%
6.0%
Q3 24
-0.6%
-151.9%
Q2 24
2.6%
-481.3%
Q1 24
-4.2%
-201.4%
EPS (diluted)
DHX
DHX
PACB
PACB
Q4 25
$0.03
$-0.11
Q3 25
$-0.10
$-0.13
Q2 25
$-0.02
$-0.14
Q1 25
$-0.21
$-1.44
Q4 24
$0.02
$-0.44
Q3 24
$0.00
$-0.22
Q2 24
$0.02
$-0.64
Q1 24
$-0.03
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHX
DHX
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$2.9M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$94.5M
$5.3M
Total Assets
$188.2M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHX
DHX
PACB
PACB
Q4 25
$2.9M
$279.5M
Q3 25
$2.3M
$298.7M
Q2 25
$2.8M
$314.7M
Q1 25
$2.7M
$343.1M
Q4 24
$3.7M
$389.9M
Q3 24
$2.1M
$471.1M
Q2 24
$3.0M
$509.8M
Q1 24
$3.2M
$561.9M
Total Debt
DHX
DHX
PACB
PACB
Q4 25
Q3 25
$30.0M
Q2 25
$30.0M
Q1 25
$33.0M
Q4 24
$32.0M
Q3 24
$32.0M
Q2 24
$35.0M
Q1 24
$41.0M
Stockholders' Equity
DHX
DHX
PACB
PACB
Q4 25
$94.5M
$5.3M
Q3 25
$97.3M
$36.1M
Q2 25
$102.5M
$61.5M
Q1 25
$103.9M
$91.6M
Q4 24
$114.3M
$506.6M
Q3 24
$111.3M
$453.1M
Q2 24
$109.8M
$492.7M
Q1 24
$106.6M
$649.0M
Total Assets
DHX
DHX
PACB
PACB
Q4 25
$188.2M
$784.1M
Q3 25
$192.5M
$803.2M
Q2 25
$204.9M
$825.5M
Q1 25
$212.1M
$860.8M
Q4 24
$221.4M
$1.3B
Q3 24
$219.4M
$1.5B
Q2 24
$224.4M
$1.5B
Q1 24
$231.9M
$1.7B
Debt / Equity
DHX
DHX
PACB
PACB
Q4 25
Q3 25
0.31×
Q2 25
0.29×
Q1 25
0.32×
Q4 24
0.28×
Q3 24
0.29×
Q2 24
0.32×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHX
DHX
PACB
PACB
Operating Cash FlowLast quarter
$7.2M
$-19.1M
Free Cash FlowOCF − Capex
$5.7M
$-19.9M
FCF MarginFCF / Revenue
18.1%
-44.6%
Capex IntensityCapex / Revenue
4.9%
1.9%
Cash ConversionOCF / Net Profit
7.60×
TTM Free Cash FlowTrailing 4 quarters
$13.8M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHX
DHX
PACB
PACB
Q4 25
$7.2M
$-19.1M
Q3 25
$4.8M
$-18.7M
Q2 25
$6.9M
$-29.4M
Q1 25
$2.2M
$-44.1M
Q4 24
$4.4M
$-30.6M
Q3 24
$5.5M
$-45.5M
Q2 24
$9.1M
$-54.3M
Q1 24
$2.1M
$-75.7M
Free Cash Flow
DHX
DHX
PACB
PACB
Q4 25
$5.7M
$-19.9M
Q3 25
$3.2M
$-18.8M
Q2 25
$4.8M
$-29.9M
Q1 25
$88.0K
$-45.4M
Q4 24
$1.6M
$-32.3M
Q3 24
$2.3M
$-46.3M
Q2 24
$5.6M
$-55.7M
Q1 24
$-2.4M
$-79.6M
FCF Margin
DHX
DHX
PACB
PACB
Q4 25
18.1%
-44.6%
Q3 25
9.9%
-48.9%
Q2 25
15.1%
-75.3%
Q1 25
0.3%
-122.3%
Q4 24
4.6%
-82.3%
Q3 24
6.5%
-115.7%
Q2 24
15.6%
-154.8%
Q1 24
-6.5%
-205.0%
Capex Intensity
DHX
DHX
PACB
PACB
Q4 25
4.9%
1.9%
Q3 25
5.0%
0.2%
Q2 25
6.3%
1.4%
Q1 25
6.7%
3.7%
Q4 24
8.0%
4.1%
Q3 24
9.2%
2.0%
Q2 24
9.7%
4.1%
Q1 24
12.3%
10.0%
Cash Conversion
DHX
DHX
PACB
PACB
Q4 25
7.60×
Q3 25
Q2 25
Q1 25
Q4 24
4.27×
-12.93×
Q3 24
Q2 24
9.61×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DHX
DHX

Clearance Jobs$17.4M56%
Clearance Jobs Segment$13.9M44%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons